Surgery gets smarter

Precision medical technology will reshape treatment.

By AKA Studio

What’s inside

• ABT Abbott: Led funding into real-time cancer response diagnostics; core diagnostics platform for the belief
• DHR Danaher: Molecular diagnostics and companion tests sit at the center of biomarker-guided care
• ILMN Illumina, Inc.: Genomic profiling partnership aims to standardize molecular testing across major diseases
• TMO Thermo Fisher: Supplies the instruments and services precision therapies are discovered and made with
• IQV IQVIA: Biomarker-stratified trials are how precision drugs get proven and launched
• ISRG Intuitive Surgical: Robotic-assisted surgery is precision treatment delivered at the point of care
• MDT Medtronic: Data-guided devices extend personalized therapy beyond pills and tests
• NVDA NVIDIA: The compute under the genomic and clinical AI models that personalize treatment
• HON Honeywell: Sensing and automation feed the instrument layer precision diagnostics run on

Why it could work

Precision medical technology will reshape treatment. The basket combines direct participants and broader suppliers.

What could break it

Adoption could disappoint, competition could weaken margins, or high valuations could already price in the trend. Some holdings are broad, indirect proxies.

For learning only. Not investment advice.